N@N

Market Maker Surveillance Report. PRKR, PPHM, DRRX, SATC, ACI, BWEN, Bearishly Biased Price Friction For Friday, June 22nd 201

^{Published on 2012-06-22 18:00:35 - WOPRAI}
 

June 22, 2012 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Friday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Friday there were 3684 companies with "abnormal" market making, 3271 companies with positive Friction Factors and 2151 companies with negative Friction Factors. Here is a list of the top companies with Abnormal Price Friction (bearish bias) in their stock prices. This means that there was more buying than selling in the stocks and their stock prices dropped. PARKERVISION INC (NASDAQ:PRKR), PEREGRINE PHARMACEUTICALS (NASDAQ:PPHM), Durect Corp (NASDAQ:DRRX), SATCON TECHNOLOGY CORP (NASDAQ:SATC), ARCH COAL INC (NYSE:ACI), BROADWIND ENERGY INC (NASDAQ:BWEN). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

  Symbol  Change    Percent   Buy Volume   Buy %%    Sell Volume  Sell %%   Net Volume   Friction
  PRKR    $-0.050   -2.24%    6,436,098    79.86%    1,034,892    12.84%    5,401,206    Abnormal
  PPHM    $-0.010   -1.29%    5,210,681    90.39%    552,951      9.59%     4,657,730    Abnormal
  DRRX    $-0.020   -2.44%    5,010,084    89.85%    565,071      10.13%    4,445,013    Abnormal
  SATC    $-0.020   -9.05%    6,258,726    77.09%    1,862,002    22.93%    4,396,724    Abnormal
  ACI     $-0.080   -1.29%    12,159,161   61.17%    3,521,959    17.72%    8,637,202    Abnormal
  BWEN    $-0.020   -7.83%    7,485,008    84.80%    1,340,550    15.19%    6,144,458    Abnormal

For example, the chart above shows PRKR with 5,401,206 greater shares of buying than selling (NetVol) and the stock price was down $-0.05000. This means the Market Makers were trading the stock in a way inconsistent with normal supply and demand (Economics 101); more buying than selling should cause prices to rise.

PARKERVISION INC (NASDAQ:PRKR) - ParkerVision, Inc. engages in the design, development, and sale of proprietary radio frequency (RF) technologies and products for use in semiconductor circuits for wireless communication products. The company offers its wireless technologies for processing RF waveforms in wireless applications. Its technology applies to transmit and receive functions of a radio transceiver. The companys transmit technology, Direct2Power, enables the transformation of a baseband signal to an RF carrier waveform at the desired power output level in a single unified operation. ParkerVisions receiver portion of the Direct2Data enables the direct conversion of an RF carrier to a baseband data signal. The company licenses its intellectual property for incorporation into wireless devices designed by its customers, as well as provides engineering consulting and design services to its customers to assist them in developing prototypes and/or products incorporating its technologies. It primarily focuses on incorporating its technologies into mobile handsets, as well as to other wireless products that are related to networks serving mobile handsets, such as data cards, femtocells, and machine-to-machine and embedded applications. The companys technology is also used in non-cellular radio applications comprising military radios. In addition, ParkerVision develops wireless radio modules for mobile handset and data card applications through a joint development and marketing agreement with LG Innotek Co., Ltd. It serves mobile handset manufacturers and their component suppliers. The company was founded in 1989 and is headquartered in Jacksonville, Florida.

PEREGRINE PHARMACEUTICALS (NASDAQ:PPHM) - Peregrine Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, engages in the development and manufacture of monoclonal antibodies for the treatment of cancer and viral infections. The company develops clinical programs with its novel compounds bavituximab and Cotara, which are the clinical candidates under its anti-phosphatidylserine therapeutics and tumor necrosis therapy platforms. Its pipeline products comprise Bavituximab Plus Docetaxel, and Bavituximab plus carboplatin and paclitaxel, which are Phase II clinical trial products for treating advanced breast cancer patients; and Bavituximab plus carboplatin and paclitaxel, a Phase II clinical trial product for the treatment of non-small cell lung cancer, as well as Bavituximab, which is in Phase I monotherapy repeat dose safety study for treating solid tumor cancers, and in Phase Ib repeat dose safety study for the treatment of chronic hepatitis C virus infection co-infected with HIV. In addition, its pipeline products include Cotara, a product in Phase II, as well as a dosimetry and dose confirmation study for the treatment of glioblastoma multiforme, an aggressive form of brain cancer. Further, Peregrine, through its wholly owned subsidiary, Avid Bioservices, Inc., provides contract manufacturing services for biotechnology and biopharmaceutical companies, from pre-clinical drug supplies up through commercial-scale drug manufacture. Further, it provides services in support of Peregrine's product pipeline, including manufacture and scale-up of pre-clinical and clinical drug supplies. The company was founded in 1981 and is based in Tustin, California.

Durect Corp (NASDAQ:DRRX) - DURECT Corporation focuses on the development of pharmaceutical products for pain, central nervous system disorders, cardiovascular disease, and other chronic diseases based on its proprietary drug formulations and delivery platform technologies. Its products include Remoxy, an oxycodone gelatin capsule for chronic pain, which is accepted as a new drug application; POSIDUR, a release formulation of bupivacaine that is under Phase III clinical trial for post operative pain; ELADUR, a transdermal bupivacaine patch, which is under Phase II clinical trial, provides continuous delivery of bupivacaine for up to three days from a single application, as well as for the treatment of pain associated with post-herpetic neuralgia; and TRANSDUR-Sufentanil, a proprietary transdermal sufentanil patch, which is under Phase II clinical trial, provides continuous delivery of sufentanil for a period of up to seven days from a single application. The companys products also comprise oral controlled release opioid for pain that is under the Phase I clinical trial; and ORADUR-ADHD, a preclinical trial product targeting attention deficit hyperactivity disorder. It markets ALZET, the miniature implantable osmotic pumps and accessories for experimental research in mice, rats, and other laboratory animals. The company also develops and manufactures various biodegradable polymers based on lactide, glycolide, and caprolactone under the LACTEL brand for pharmaceutical and medical device clients, as well as conducts research and development of pharmaceutical products in collaboration with third party pharmaceutical and biotechnology companies. The company has strategic agreements with Alpharma Ireland Limited; Nycomed Danmark, ApS; Pain Therapeutics, Inc.; Endo Pharmaceuticals Inc; Curaxis Pharmaceutical Corporation; ALZA Corporation; EpiCept Corporation; NeuroSystec Corporation; and King Pharmaceuticals, Inc. DURECT Corporation was founded in 1998 and is based in Cupertino, California.

SATCON TECHNOLOGY CORP (NASDAQ:SATC) - Satcon Technology Corporation provides a suite of utility grade power conversion solutions and services for commercial and utility scale renewable energy installations and distributed energy markets in the United States and internationally. Its renewable energy solutions include utility grade inverters for solar photovoltaic and fuel cell applications that offer modular inverters for use in connection with large, utility-scale, renewable energy power systems, such as stationary fuel cell power plants, photovoltaic power plants, and distributed power generation systems. The companys PowerGate Plus inverters convert the DC power generated by a renewable energy source into useable AC power; and provides an interface with the electric utility grid, an energy storage device, and end user applications. Satcon Technology Corporations renewable energy solutions also comprise micro grid solutions that provide stable renewable power locally, at the point of demand. Its micro grid solutions also offer uninterupted utility grade renewable energy to deliver the energy security. Satcon Technology Corporation sells its products and services through direct sales personnel, distributors, and sales agents. The company was founded in 1985 and is headquartered in Boston, Massachusetts.

ARCH COAL INC (NYSE:ACI) - Arch Coal, Inc. engages in the production and sale of steam and metallurgical coal from surface and underground mines located throughout the United States As of December 31, 2010, it operated or contracted out the operation of 23 active mines; and owned or controlled approximately 4.4 billion tons of estimated proven and probable recoverable reserves. The company owned or controlled primarily through long-term leases, approximately 100,132 acres of coal land in West Virginia; 107,812 acres of coal land in Wyoming; 98,982 acres of coal land in Illinois; 73,361 acres of coal land in Utah; 49,069 acres of coal land in Kentucky; 18,114 acres of coal land in Montana; 21,798 acres of coal land in New Mexico; and 18,521 acres of coal land in Colorado, as well as owned or controlled through long-term leases smaller parcels of property in Alabama, Indiana, and Texas. Arch Coal, Inc. sells its products to coal-fueled power plants, industrial facilities, and steel mills worldwide. The company was founded in 1969 and is headquartered in St. Louis, Missouri.

BROADWIND ENERGY INC (NASDAQ:BWEN) - Broadwind Energy, Inc. provides products and services to the wind energy industry primarily in the United States. Its Towers segment manufactures wind towers designed for 2 megawatt and larger wind turbines. This segment also offers other specialty weldments and structures for industrial customers. The companys Gearing segment manufactures precision gearing systems, as well as products for industrial markets, including mining and oilfield equipment. Its Technical and Engineering Services segment offers construction support, and operations and maintenance services that include assembly of towers, nacelles, blades, and other components; customer support; preventive maintenance; wind technician training; and repair and engineering services. This segment also conducts warranty inspections, commissions turbines, and provides technical assistance. In addition, it provides specialty services comprising oil change-out, up-tower tooling for gearing systems, drive-train and blade repairs, and component replacement; builds replacement control panels for kilowatt class wind turbines; and repairs kilowatt and megawatt blades. The companys Logistics segment offers transportation, permitting, and logistics management services for oversize and overweight machinery and equipment by delivering turbines to the installation site, including blades, nacelles and tower sections for final erection. This segment also focuses on the project management of the delivery of complete wind turbine farms. The company provides its products and services to various wind energy customers that include wind turbine manufacturers, wind farm developers, and wind farm operators, as well as oil and gas, mining, and other industries. It sells its products through its sales force and manufacturers' representatives. The company was formerly known as Tower Tech Holdings Inc. and changed its name to Broadwind Energy, Inc. in 2008. Broadwind Energy, Inc. is headquartered in Naperville, Illinois.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net